References
- Mosgaard B, Lidegaard O, Andersen AN. Use of fertility drugs in Denmark 1973–1993. An analysis based on sale statistics. Acta Obstet Gynecol Scand 1995; 74: 614–8
- Fishel S, Jackson R. Follicular stimulation for high tech pregnancies: are we playing it safe?. Br Med J 1989; 299: 309–11
- Whittemore AS, Harris R, Itnyre J, The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of twelve US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136: 1184–1203
- Brzezmski A., Peretz T, Mor-Yosef S, Schenker JG. Ovarian stimulation and breast cancer: is there a link?. Gynecol Oncol 1994; 52: 292–5
- Rossing MA, Dahng JR, Weiss NS, Moore DE, Self SG. Ovarian tumours in a cohort of infertile women. N Engl J Med 1994; 331: 771–6
- Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346: 995–1000
- Willemsen W, Kruitwagen R, Bastiaans B, Hanselaar T, Rolland R. Ovarian stimulation and granulosa-cell tumour. Lancet 1993; 341: 986–8
- Balasch J, Barri PN. Follicular stimulation and ovarian cancer?. Hum Reprod 1993; 8: 990–6
- Lais CW, Williams TJ, Gaffey TA. Prevalence of ovarian cancer found at the time of infertility microsurgery. Fertil Steril 1988; 49: 551–3